[2251]
New option to prevent breast cancer recurrence
[1273,8 KB]
From [lombardi.georgetown.edu] Last viewed: 13.07.2004
A
new drug reduced almost by
half the risk that post-
menopausal survivors of early-
stage breast cancer would suf-
fer a relapse, according to an internation-
al study released in October. The drug,
letrozole (sold as Femara), brings new
hope for a disease-free future for hun-
dreds of thousands of breast cancer sur-
vivors.
The international study of more than
5,000 postmenopausal women found that
letrozole, when taken shortly after com-
pleting five years of tamoxifen therapy,
cut estrogen-sensitive breast cancer
recurrences by almost half. These results
were so persuasive that the study was
halted early to get the news to the public
and allow women to begin the therapy.
Lombardi Comprehensive Cancer
Center is one of the sites that enrolled
patients on this study. Claudine Isaacs,
MD, associate professor and clinical
director ...
[2252]
MISSION The mission of Y-ME National Breast Cancer Organization is ...
[84,1 KB]
From [www.y-me.org] Last viewed: 13.07.2004
MISSION
The mission of Y-ME National Breast Cancer
Organization is to ensure, through information,
empowerment and peer support, that no one faces
breast cancer alone.
NATIONAL PROGRAMS & SERVICES
24-hour Y-ME National Breast Cancer Hotline
1-800-221-2141 (English)* • 1-800-986-9505 (Spanish)
The only hotline in the United States staffed by trained peer counselors who are breast cancer
survivors. It is a convenient, confidential resource for breast cancer and breast health information, as
well as support for anyone touched by or concerned about this disease. Callers can be matched with
a survivor, patient and/or supporter who have had a similar experience with breast cancer .
* Interpreters available in 150 languages.
ShareRing Network
A monthly, one-hour teleconference featuring a breast cancer related presentation ...
[2253]
Understanding Your Breast Cancer Pathology Report
[104,6 KB]
From [www.y-me.org] Last viewed: 13.07.2004
Y-ME National
Breast Cancer
Organization
TM
guide
Understanding Your
Breast Cancer
Pathology Report
A Guide for
Breast Cancer
Patients
Page 2
pathology repor
our
t
Being diagnosed with breast cancer is a
life-changing event. There are many different
emotional reactions to deal with and an
enormous amount of information to learn.
A call to the Y-ME National Breast Cancer
Hotline can help with both.
Newly diagnosed women and men, their
families and friends, need information that will
educate them about breast cancer , possible
treatments and prognosis. The pathology
report can be a major source of this
information. Unfortunately, the pathology
report is sometimes written in terms that
frequently only pathologists and other medical ...
[2254]
Y-ME National Breast Cancer Organization
[344,7 KB]
From [www.y-me.org] Last viewed: 13.07.2004
A Woman’s Guide
to Breast Care
Y-ME National
Breast Cancer
Organization
TM
Page 2
Breast self-examination (BSE) takes just a few
minutes, and you only do it once a month. As you
do your examination, keep in mind that your goal
is to become acquainted with how your breasts
normally LOOK and FEEL. You will become more
familiar with your breasts if you perform BSE on a
regular basis. This knowledge may help you
identify a change, which should be reported to
your medical professional.
What changes should I look for?
• Lump or thickening in or near the breast or
underarm area
• Change in the size and/or shape of the breast
• Puckering, dimpling and/or redness of the
breast skin
• Scaliness, redness, itching and/or swelling of
the nipple or surrounding area
When should I perform BSE? ...
[2255]
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Breast Cancer
[99,3 KB]
From [www.mass.gov] Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES
Source: Community Assessment Program, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health
December, 2002
Breast Cancer
Breast cancer is the most frequently diagnosed cancer among women in both the United States and
in Massachusetts. According to the North American Association of Central Cancer Registries,
female breast cancer incidence in Massachusetts is the fifth highest among all states (Chen et al,
2000). Although during the 1980s breast cancer in the U.S. increased by about 4% per year, the
incidence has leveled off to about 110.6 cases per 100,000 (ACS 2000). A similar trend occurred
in Massachusetts and there was even a slight decrease in incidence (1%) between 1993 and 1997
(MCR 2000).
In the year 2002, approximately 203,500 women in the U.S. will be diagnosed ...
[2256]
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Breast Cancer
[121,2 KB]
From [www.mass.gov] Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES
Breast Cancer
Breast cancer is the most frequently diagnosed cancer among women in both the United States and
in Massachusetts. According to the North American Association of Central Cancer Registries,
female breast cancer incidence in Massachusetts is the fifth highest among all states (Chen et al,
2000). Although during the 1980s breast cancer in the U.S. increased by about 4% per year, the
incidence has leveled off to about 110.6 cases per 100,000 (ACS 2000). A similar trend occurred
in Massachusetts and there was even a slight decrease in incidence (1%) between 1993 and 1997
(MCR 2000).
In the year 2003, approximately 211,300 women in the U.S. will be diagnosed with breast cancer
(ACS 2003). Worldwide, female breast cancer incidence has increased, mainly among women in
older age groups whose ...
[2257]
Pioneering breast cancer research
[670,1 KB]
From [www.extra.rdg.ac.uk] Last viewed: 13.07.2004
Diana Moran. Patron of the Breast Cancer Campaign, visited the University recently to see
the work of Dr Philippa Darbre in the School of Animal and Microbial Sciences
October
2002
The Breast Cancer
Campaign has
awarded Dr Phillipa
Darbre from the
School of Animal and
Microbial Sciences
£78,500 over three
years to research into
why some patients
develop a resistance to
hormone therapy and
when this is likely to
happen. Treatments
could then be
alternated, which will
provide much more
effective treatment
and prolong life
expectancy. Dr Darbre
said, “Hormone
therapy works for
people for varying
lengths of time but
eventually it fails. At the
Pioneering breast cancer research
Did you know that
there are at least 165
species of spider within
a 1km radius of the
University ...
[2258]
you can help breast cancer
[139,0 KB]
From [www.breastcancercare.org.uk] Last viewed: 13.07.2004
How
you can help
people with
breast cancer
VOLUNTEERING FOR
BREAST CANCER CARE
Page 2
Volunteers play
a central and
important role in
helping us deliver
our services at
national, regional
and local levels.
They are vital to the
organisation and
highly valued by
Breast Cancer Care
staff and clients.
Page 3
What can volunteers do?
Health promotion and outreach volunteers
raise awareness about Breast Cancer Care and
breast awareness in their local community by
giving out information and attending events
on our behalf.
Volunteer peer supporters offer one-to-one
support to people with breast cancer and their
partners, usually by telephone (for this you
must have personal experience of breast
cancer ...
[2259]
Prof. Chris Robertson Age at any birth and Breast Cancer Risk
[7,1 KB]
From [www.stams.strath.ac.uk] Last viewed: 13.07.2004
Prof. Chris Robertson
Age at any birth and Breast Cancer Risk
This project will review previously published models of the effect of parity and age at
any birth on breast cancer risk. These models are conceptually similar and one aim is
to write a general model such that various restrictions on the parameters of the
general model yield the specific models. A second aim is to apply these models to a
large series of Case Control studies. I expect that there will be developments in the
areas of using spline functions and other flexible curves to improve the validity of the
models.
Background.
Parity and age at first birth have long been identified as risk factors for breast cancer .
Relative to nulliparous women, parous women have a decreased risk of breast cancer .
The risk of developing breast cancer is greater among women with a later age at first
birth compared ...
[2260]
Continuing to Reduce the Excess Burden of Breast Cancer Incidence ...
[125,1 KB]
From [www.cbcrp.org] Last viewed: 13.07.2004
Continuing to Reduce the Excess Burden
of Breast Cancer Incidence and Mortality
among California Women
Ngina Lythcott, Dr.P.H.
Page 2
1
Introduction
This paper is written from the perspective of a breast
cancer survivor-advocate. While the writer is trained as
a public health professional and is a fifteen-year
survivor of breast cancer , she writes this paper from
her experience working with and supporting many
hundreds of women who have had an initial diagnosis
of breast cancer or a reoccurrence of the disease. It is
this experience that motivates the writer’s interest in
and influences much of her thinking about the
important role of breast cancer research in the
reduction of excess burden and the eradication of the
disease.
12
The focus of this paper is the reduction of excess ...
[2261]
Breast Cancer in the Family - What does this mean for you?
[77,4 KB]
From [www.bshg.org.uk] Last viewed: 13.07.2004
Breast Cancer
in the Family -
What does this
mean for you?
Information for women
with a low or moderate
lifetime risk of breast
cancer
Last updated Mar 2002
Seen in clinic by.
CLIN
ICAL GENETICS CLINICAL G
ENE
TICS
For more information:
If you need more advice about any aspect of
inherited cancer , you are welcome to contact:
Clinical Genetics Department
7th Floor, New Guy's House
Guy's Hospital, St. Thomas Street
London SE1 9RT
Telephone: 020 7955 4648
Facsimile: 020 7955 2550
Page 2
We hear a lot about "inherited breast cancer ". This
can be confusing and alarming.
As breast cancer is fairly common, many women
have at least one relative with this type of cancer .
Yet most of those women do not have an "inherited"
type of breast ...
[2262]
National Breast Cancer Awareness Month, 2003
[33,0 KB]
From [a257.g.akamaitech.net] Last viewed: 13.07.2004
115
Proclamations
Proc. 7711
Americans to celebrate this week with appropriate programs, ceremonies,
and activities to recognize the many contributions of our Nation’s minority
enterprises.
IN WITNESS WHEREOF, I have hereunto set my hand this twenty-six day
of September, in the year of our Lord two thousand three, and of the Inde-
pendence of the United States of America the two hundred and twenty-
eighth.
GEORGE W. BUSH
Proclamation 7711 of October 3, 2003
National Breast Cancer Awareness Month, 2003
By the President of the United States of America
A Proclamation
Breast cancer touches the lives of many Americans, either directly or
through the diagnosis of a family member or friend. We have made consid-
erable progress in diagnosing this disease and improving treatments, but we
have not ended it. While overall death rates are declining, ...
[2263]
THE REGISTRATION OF BREAST CANCER
[2799,6 KB]
From [www.thames-cancer-reg.org.uk] Last viewed: 13.07.2004
breast
cancer
1
THE REGISTRATION OF BREAST CANCER
The anatomy of the breast , the pathology and treatment of breast cancer , and collecting breast cancer data
2
FIVE FACTS ABOUT BREAST CANCER
Incidence:
1 in 9 women in the TCR area develop breast cancer during their lifetime.
0.5% of breast cancer cases occur in men.
Survival:
Now improving. Depends on stage at diagnosis.
90% at 5yrs for localised disease, 77% at 5 yrs if lymph nodes involved.
Most common agegroup:
50 - 70 yrs
Population most at risk:
A disease of the western ...
[2264]
i Susceptibility genes in hereditary breast cancer
[18,7 KB]
From [www.nfog.org] Last viewed: 13.07.2004
i
Susceptibility genes in hereditary breast cancer
Department of Obstetrics and Gynecology, Helsinki University Central Hospital
Pia Vahteristo, email: pia.vahteristo@helsinki.fi
Breast cancer is the most common malignancy among women worldwide. Most cases are sporadic,
but an estimated 5-10% are due to hereditary predisposition. Two major susceptibility genes,
BRCA1 and BRCA2 , have thus far been identified. Germline mutations in BRCA1 and BRCA2
explain the majority of families with both early-onset breast cancer and ovarian cancer , but a
considerably lower fraction of families with site-specific breast cancer . This suggests the presence
of other predisposing genes. The contribution of BRCA1 and BRCA2 to breast cancer incidence
remains also unresolved, presumably because most studies have focused on high-risk families with
multiple affected relatives, on ...
[2265]
Breast Cancer Report Card.qxp
[74,3 KB]
From [www2.kcr.uky.edu] Last viewed: 13.07.2004
K
ENTUCKY
B
REAST
C
ANCER
T
ASK
F
ORCE
R
EPORT
C
ARD
O
CTOBER
2003
This report card was prepared by
Gilbert H. Friedell, M.D., Linda Linville,
Ph.D., Connie Sorrell, M.P.H.,
Bin Huang, M.S., and Joe Petrik, M.A., M.Sc.
Dr. Friedell is Director Emeritus of the
Markey Cancer Center, University of
Kentucky and Executive Director of the
Kentucky Breast Cancer Task Force.
Dr. Linville is Director, Cancer Control
Practice, Markey Cancer Control Program,
University of Kentucky and Co-Director of
the Kentucky Breast Cancer Task Force.
Ms. Sorrell is Director, Kentucky Cancer
Program, Brown Cancer Center, University
of Louisville and Co-Director of the
Kentucky Breast Cancer ...
[2266]
Breast Cancer
[215,5 KB]
From [www.radiologyinfo.org] Last viewed: 13.07.2004
FOR IMMEDIATE RELEASE
08/19/03
For more information:
shughes@wellnesscommunitytn.org
Newly Diagnosed with Breast Cancer ? There is Help.
A New Support Group brought to you by The Wellness Community
Knoxville, TN (August 19, 2003) – The Wellness Community, a national
non-profit organization based in Knoxville, will be starting a specialized
support and education group targeting females who are Newly
Diagnosed with Breast Cancer . This unique 10-week program,
starting September 18
th
at 10am, will feature information on education
and support designed to help patients navigate through the maze of
decisions and emotions accompanying the diagnosis of breast cancer .
Each 2-hour meeting allows an hour for an educational program and
another hour for questions, answers, and sharing among participants.
Betsy Boyd, breast cancer ...
[2267]
Breast Cancer Bulletin
[165,4 KB]
From [www.breakthrough.org.uk] Last viewed: 13.07.2004
Breast Cancer Bulletin
October 2003
October 2003 marks the 10th anniversary of
Breast Cancer Awareness Month – one of the key
health awareness campaigns in the UK.
Breast cancer is the most common form of cancer in the UK
and this country has one of the highest rates in Europe. We
have seen a worrying rise in UK incidences of breast cancer —
according to the latest statistics available, over 40,000 women
and around 300 men are now being diagnosed with the
disease every year ( Breast Cancer Forum statistics, July 2003).
The good news is more women are surviving than ever
before. According to the latest statistics, the five year survival
rate for women diagnosed with breast cancer is now 74%
( Breast Cancer Forum statistics, July 2003).
However, we cannot afford to become complacent on the
issue as an average of 1,000 ...
[2268]
Breast Cancer Bulletin
[217,4 KB]
From [www.breakthrough.org.uk] Last viewed: 13.07.2004
Breast Cancer Bulletin
February 2004
Members of the Group held health minister Melanie Johnson
accountable on areas ranging from the importance of
research into how to prevent breast cancer , to the patenting
of the two known genes (BRCA1 and BRCA2) involved in
familial breast cancer , to the series of targets for breast
cancer set out in the NHS Cancer Plan.
Screening
Members paid particular attention to the low uptake in some
areas of invitations for routine appointments with the NHS
Breast Screening Programme. Long delays in diagnosis also
caused concern.
Whilst acknowledging the overall success of the screening
programme, which celebrated its 15th anniversary in 2003,
former Joint Chair Alice Mahon MP raised concerns over the
low uptake of invitations to screening appointments in some
areas of the country, in particular across ...
[2269]
3/22/2004 Association of antibiotic use with breast cancer Word ...
[13,9 KB]
From [www.aad.org] Last viewed: 13.07.2004
3/22/2004
Association of antibiotic use with breast cancer
Word Count – 248
To the Editor: In a recent article in JAMA, Velicer et al (1) performed a case-control
study involving patients enrolled in an HMO and concluded, “use of antibiotics is
associated with increased risk of incident and fatal breast cancer .” This would seem to
demand a change in medical practice; however, it belies potent design flaws of the study.
First, the analysis lacks a test of specificity; that is, to both show the presence of an
association where postulated as well as a lack of association where not expected (e.g.,
that prescriptions of antihypertensives, antidepressants, or other common medications are
uncorrelated with breast cancer risk). A classic example of such a problem is the report
linking reserpine to breast cancer some 30 years ago that was later refuted (2). Second,
although the ...
[2270]
About Rethink Breast Cancer
[62,3 KB]
From [www.grousemountain.com] Last viewed: 13.07.2004
About Rethink Breast Cancer
Rethink Breast Cancer is fighting breast cancer and expanding support for the cause through innovative research
and awareness. We are a national volunteer-driven charity with a bold, enterprising and entrepreneurial
approach. Rethink uses creative and unconventional ways to communicate about breast cancer in order to
transform attitudes, debunk myths and reach women and men who feel unaffected by the breast cancer cause.
Rethink is tapping into the art, entertainment and fashion communities to re-energize the breast cancer
movement and tackle the serious issues of breast cancer in a creative and strongly positive way.
Our Audience
Rethink Breast Cancer ’s target audience is modern, bold, youthful minded, upbeat, media savvy, highly
interactive and culturally aware. These are people who may not be currently responding to the breast ...
[2271]
Breast Cancer: The Risks By Lisa Smedman and Nina K. Tryggvason ...
[12,5 KB]
From [www.lavenderproductions.com] Last viewed: 13.07.2004
Breast Cancer : The Risks
By Lisa Smedman and Nina K. Tryggvason
1,192 words
Are lesbians at higher risk for breast cancer ? In 1993, the queer and mainstream
press sounded a dire warning: lesbians had a one in three chance of developing breast
cancer ., while the general cancer rate for women is one in nine.
The one-in-three rate was derived from a July 1993 by The National Gay and
Lesbian Task Force. The paper reported that: lesbians theoretically have a two to three
times greater risk of developing breast cancer and gynecologic cancers. It found high
incidences of smoking, drinking and weight problems in those aged 50 and up in the
sample group and that 75 to 84 per cent of lesbians have a low rate of childbearing,
thereby doubling the risk. Heavy alcohol consumption by 25 per cent of lesbians aged
40 and up, increases risk by 1.6. Despite these higher risks, lesbians ...
[2272]
West Penn Hospital Launches Breast Cancer Support Group
[65,4 KB]
From [www.pittsburghraceforthecure.org] Last viewed: 13.07.2004
West Penn Hospital Launches Breast Cancer Support Group
West Penn Hospital and the Cancer Caring Center are proud to offer a new support group for breast
cancer patients. The group meets at West Penn Hospital on the second Wednesday of each month
from 6:30 to 8 p.m.
A trained facilitator leads the discussion and sharing and a physician is be available at the beginning
of each session to answer questions. Light refreshments and complimentary parking are provided.
For more information or to register, please contact the Cancer Caring Center at (412) 622-1212.
Workshop Helps Women with Cancer Look Good, Feel Better
West Penn Hospital has introduced a new workshop to help female cancer patients look and feel their
best during treatment.
Look Good Feel Better is a free program sponsored by the American Cancer Society, the
Cosmetic, Toiletry and Fragrance Association Foundation, ...
[2273]
BATTLING against Breast Cancer
[309,1 KB]
From [law.wustl.edu] Last viewed: 13.07.2004
J
udy Katz typed her
son’s college papers.
She buoyed him emo-
tionally when organic
chemistry caused him
to drop his pre-med pro-
gram. She encouraged him
throughout his law studies. “My mother
supported me in everything I did,”
Michael B. Katz, JD ’88, states simply.
She also left her son a legacy of
generosity. “I realized that my mother’s
generosity had a life-embracing effect
on me,” he says. “She did not teach me
how to make a living, but how to live
by giving.”
Judy Katz was diagnosed with
breast cancer when she was 34 and her
son, 11. “She never asked, ‘Why me?’ ”
says Michael Katz, “She continued to
live life by reaching out to help others.
For my mom, breast cancer wasn’t
about dying; it was just one more
reinforcement about living.”
After a 17-year remission, the dis-
ease returned in 1990. Judy Katz died
in ...
[2274]
Visit of the Breast Cancer Alliance of Greenwich to
[20,5 KB]
From [info.med.yale.edu] Last viewed: 13.07.2004
breast
cancer
Visit of the Breast Cancer Alliance of Greenwich to
Yale Cancer Center, Tuesday, May 4, 2004
On Tuesday, May 4, 2004, the Breast Cancer Alliance, Inc. of Greenwich will visit Yale Cancer Center for luncheon to hear presentations from physicians and researchers who wish to apply for awards this year.
The mission of the Breast Cancer Alliance is to fund innovative breast cancer research and to promote breast health through education and outreach. They provide funding for the following:
A diversified portfolio of research with an emphasis on programs that have not yet qualified for Federal monies.
Purchase of equipment for research.
Breast cancer education and outreach.
Since 1997, the Breast Cancer Alliance has awarded over $800,000 ...
[2275]
Yoga Unites for Living Beyond Breast Cancer Yoga Unites for Living ...
[1609,1 KB]
From [www.lbbc.org] Last viewed: 13.07.2004
Sunday
May 23, 2004
8:00 a.m. – 12:00 p.m.
East Entrance Steps,
Philadelphia Museum of Art
All ages and skill levels welcome.
All proceeds benefit Living Beyond
Breast Cancer ’s education and
support programs.
Philadelphia
Yoga Unites for
Living Beyond
Breast Cancer
A large-scale
outdoor yoga class and
Healthy Living Expo.
Presented by
Yoga
Unites
for
Living
Beyond
Breast
Cancer
10 East Athens A
ve.
Suite 204
Ardmore, P
A 19003
NON-PROFIT ORG.
US POST
AGE
PAID
Lancaster P
A
Permit No. 472
Special thanks to the Yoga
Unites sponsors whose
generous contributions make
this program possible.
Benefactor
Patrons
Anonymous (3)
In-Kind Sponsors ...
[2276]
Breast Cancer
[88,1 KB]
From [www.rgu.ac.uk] Last viewed: 13.07.2004
A NATIONAL EDUCATION INITIATIVE
Implementation of Guidelines in
Breast Cancer
A Workshop for
Allied Health Professionals and Nurses
at
St Margaret’s Hospice
Education Centre, Clydebank
9am • Monday 5th April 2004
Co-ordinated by: CeNPRaD, The Robert Gordon University, Aberdeen
Supported by:
SIGN®
Endorsed by:
NHS QIS and Marie Curie Cancer Care
Quality
Improvement
Scotland
THE
ROBERT GORDON
UNIVERSITY
REGISTRATION FORM • Part 2 of 2
AUDIT
This education conference focuses on guidelines and audit. In order that we may
stay focused in clinical reality we ask for your help by carrying out a brief pre-
conference audit:
I would be willing to complete an audit relating to breast care services
where I work in order to feed into the education day’s workshops. ...
[2277]
Breast cancer (non-metastatic) Women’s health
[38,9 KB]
From [www.clinicalevidence.com] Last viewed: 13.07.2004
Breast cancer (non-metastatic)
Search date October 2002
J Michael Dixon, Kate Gregory, Stephen Johnston, and Alan Rodger
What are the effects of treatments for ductal carcinoma in
situ?
LIKELY TO BE BENEFICIAL
Radiotherapy after breast conserving surgery (reduces recurrence)
RCTs found that radiotherapy
reduced the risk of local recurrence and invasive
carcinoma, with no evidence of an effect on survival.
Tamoxifen plus radiotherapy after breast conserving surgery (reduces
recurrence)
One RCT has found that adjuvant
tamoxifen
significantly reduces breast
cancer events in women who have undergone wide excision and radiotherapy, but
found no significant difference in overall survival at about 6 years.
What are the effects of treatments for operable breast
cancer ?
BENEFICIAL
Adjuvant chemotherapy
One systematic review ...
[2278]
Breast Cancer Alliance, Inc
[32,8 KB]
From [www.breastcanceralliance.org] Last viewed: 13.07.2004
breast
cancer
Breast Cancer Alliance, Inc.
115 East Putnam Avenue, 2nd Floor
Greenwich, CT 06830
203.861.0014
www.breastcanceralliance.org
Young Investigator Grant Application 2004
To encourage a commitment to breast cancer research, the Breast Cancer Alliance invites doctors and scientists who are within three years of appointment to an independent position equivalent to Assistant Professor, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions in southern New England and the mid-Atlantic states.
Mission Statement: The mission of the Breast Cancer Alliance is to fund innovative breast cancer research and to promote breast health through education and outreach. Breast cancer survivors, their friends and health-care professionals are fulfilling this mission. To accomplish this, the Breast ...
[2279]
Breast Cancer Alliance, Inc
[26,6 KB]
From [www.breastcanceralliance.org] Last viewed: 13.07.2004
breast
cancer
Breast Cancer Alliance, Inc.
115 East Putnam Avenue, 2nd Floor
Greenwich, CT 06830
203.861.0014
www.breastcanceralliance.org
Education/Outreach Grant Application 2004
Mission Statement: The mission of the Breast Cancer Alliance is to fund innovative breast cancer research and to promote breast health through education and outreach. Breast cancer survivors, their friends and health-care professionals are fulfilling this mission. To accomplish this, the Breast Cancer Alliance: ? Funds a diversified portfolio of research with an emphasis on programs that have not yet qualified for federal grants ? Funds the purchase of equipment for research and diagnosis ? Provides timely information on breast health and the importance of early detection ? Supports workshops, counseling and free ...
[2280]
Breast cancer
[272,1 KB]
From [www.curie.fr] Last viewed: 13.07.2004
1/2
Press release, 30 march 2004
Breast cancer
Discovery of a new tumor marker
At the Curie Institute in Paris, CNRS researchers have discovered a new proliferation marker : the
CAF-1 complex. Since deregulated cell proliferation is one of the most characteristic features of
tumor cells, this discovery represents a breakthrough in the cancer field. The researchers from the
Curie Institute have already validated the use of this complex as a tumor marker in the context of
breast cancer , the most frequent cancer in women.
By combining this marker with other tumor indicators, it will be possible to better characterize
tumoral cells and thus to refine diagnosis and develop targeted therapies.
These results are published in the April 1
st
, 2004 issue of
Cancer Research .
Cancer is a disease of the cell. Upon accumulation ...